4//SEC Filing
SCHIFF ANDREW N 4
Accession 0001415889-23-010090
CIK 0001783032other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:09 PM ET
Size
12.7 KB
Accession
0001415889-23-010090
Insider Transaction Report
Form 4
Aisling Capital IV, LP
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2023-06-16+31,238→ 31,238 total(indirect: See footnote)Exercise: $1.47Exp: 2033-06-15→ Common Stock (31,238 underlying)
Aisling Capital Partners IV LLC
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2023-06-16+31,238→ 31,238 total(indirect: See footnote)Exercise: $1.47Exp: 2033-06-15→ Common Stock (31,238 underlying)
Aisling Capital Partners IV, LP
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2023-06-16+31,238→ 31,238 total(indirect: See footnote)Exercise: $1.47Exp: 2033-06-15→ Common Stock (31,238 underlying)
ELMS STEVE
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-16+31,238→ 31,238 total(indirect: See footnote)Exercise: $1.47Exp: 2033-06-15→ Common Stock (31,238 underlying)
SCHIFF ANDREW N
Other
Transactions
- Award
Stock Option (Right to Buy)
2023-06-16+31,238→ 31,238 total(indirect: See footnote)Exercise: $1.47Exp: 2033-06-15→ Common Stock (31,238 underlying)
Footnotes (2)
- [F1]The stock option vests as to 100% of the total shares on the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
- [F2]This stock option was granted to Steven Elms, an employee of Aisling Capital, in his capacity as a director of the Issuer. Pursuant to the policies of Aisling Capital, Mr. Elms does not have any right to any of the Issuer's securities issued as part of his service on the Board and Aisling Capital is entitled to receive all of the pecuniary interest in the securities issued.
Documents
Issuer
Elevation Oncology, Inc.
CIK 0001783032
Entity typeother
Related Parties
1- filerCIK 0001172252
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:09 PM ET
- Size
- 12.7 KB